Figure S1 from ASCL1 Drives Tolerance to Osimertinib in <i>EGFR</i> Mutant Lung Cancer in Permissive Cellular Contexts

作者：Bomiao Hu, Marc Wiesehöfer, Fernando J. de Miguel, Zongzhi Liu, Lok-Hei Chan, Jungmin Choi, Mary Ann Melnick, Anna Arnal Estape, Zenta Walther, Dejian Zhao, Francesc López‐Giráldez, Anna Wurtz, Guoping Cai, Rong Fan, Scott Gettinger, Andrew Xiao, Qin Yan, Robert Homer, Don X. Nguyen, Katerina Politi · 年份：2024 · DOI：10.1158/0008-5472.25785287 · 研究领域：Lung Cancer Treatments and Mutations、Colorectal Cancer Treatments and Studies、Cytokine Signaling Pathways and Interactions

<p>Effects of erlotinib and TKI withdrawal on PDX growth.</p>